Lipocine Inc. (LPCN)
NASDAQ: LPCN · Real-Time Price · USD
2.060
-0.030 (-1.44%)
At close: Aug 24, 2026, 4:00 PM EDT
2.060
0.00 (0.00%)
After-hours: Aug 24, 2026, 4:10 PM EDT
Lipocine Employees
Lipocine had 14 employees as of December 31, 2025. The number of employees decreased by 2 or -12.50% compared to the previous year.
Employees
14
Change (1Y)
-2
Growth (1Y)
-12.50%
Revenue / Employee
$112,104
Profits / Employee
-$846,529
Market Cap
16.98M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 14 | -2 | -12.50% |
| Dec 31, 2024 | 16 | -1 | -5.88% |
| Dec 31, 2023 | 17 | 0 | - |
| Dec 31, 2022 | 17 | 4 | 30.77% |
| Sep 30, 2022 | 17 | 4 | 30.77% |
| Jun 30, 2022 | 15 | 2 | 15.38% |
| Mar 31, 2022 | 13 | 0 | - |
| Dec 31, 2021 | 13 | 2 | 18.18% |
| Sep 30, 2021 | 13 | 2 | 18.18% |
| Jun 30, 2021 | 13 | - | - |
| Mar 31, 2021 | 13 | 1 | 8.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Pluri | 142 |
| Palatin Technologies | 29 |
| Citius Pharmaceuticals | 23 |
| NewcelX | 12 |
| Psyence Biomedical | 12 |
| Lexaria Bioscience | 7 |
| Intensity Therapeutics | 7 |
| KALA BIO | 6 |
LPCN News
- 20 days ago - Lipocine reports Q2 EPS (32c) vs. (41c) last year - TheFly
- 20 days ago - Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2026 - PRNewsWire
- 20 days ago - Lipocine Quarterly report: Q2 2026 - Filings
- 20 days ago - Lipocine Earnings release: Q2 2026 - Filings
- 21 days ago - Lipocine Appoints Michael J. Grissinger to Board of Directors - PRNewsWire
- 2 months ago - Lipocine Transcript: KOL event - Transcripts
- 2 months ago - Lipocine Slides: KOL event - Filings
- 2 months ago - Lipocine Inc. to Host Virtual KOL Event Highlighting Unmet Needs in Postpartum Depression and the Clinical Profile of LPCN 1154 - PRNewsWire